53
Participants
Start Date
March 6, 2020
Primary Completion Date
October 3, 2023
Study Completion Date
November 15, 2023
Ibezapolstat
Investigational antibacterial agent
Vancomycin
Active comparator
Acurx Site #130: Dr Michael DiGiovanna, North Massapequa
Acurx Site #106: Dr Bezawit Tekola, Fairfax
Acurx Site #109: Dr Robert Brennan, Lynchburg
Acurx Site #127: Dr Christopher Connolley, Winston-Salem
Acurx Site #126: Dr Andrew Pearson, Myrtle Beach
Acurx Site #117: Dr Rafael Companioni, Panama City
Acurx Site #101: Dr Idalia Acosta, Miami
Acurx Site #124: Dr Yunior Silva-Barrero, Miami
Acurx Site #108: Dr Idania Garcia Del Sol, Miami
Acurx Site #116: Dr Erick Juarez, Miami
Acurx Site #105, Doral
Acurx Site #107: Dr Belkis Delgado, Miami Springs
Acurx Site #122: Dr Faride Ramos, Doral
Acurx Site #119: Dr Jorge Paoli-Bruno, Miami
Acurx Site #114: Dr Eugene Ryan, Chattanooga
Acurx Site #103: Dr John Pullman, Butte
Acurx Site #113: Dr Jennifer Vincent, Temple
Acurx Site #120: Dr Vanna Gold, Lampasas
Acurx Site #121: Dr Ramesh Gowrappala, Houston
Acurx Site #102: Dr Richard Nathan, Idaho Falls
Acurx Site #110: Dr Val Hansen, Bountiful
Acurx Site #118: Dr Janet Reiser, Scottsdale
Acurx Site #131: Dr Michael Jardula, Palm Springs
Acurx Site #115: Dr Neera Grover, Apple Valley
Acurx Site #125: Dr Karen Simon, Camarillo
Acurx Site #111: Dr Jatinder Pruthi, Lancaster
Acurx Site #129: Dr Stuart Cohen, Sacramento
Acurx Site #123: Dr Harry Schrager, Newton
Acurx Site #104: Dr JeanMarie Houghton, Worcester
Lead Sponsor
Acurx Pharmaceuticals Inc.
INDUSTRY